Labeling Recommendations

https://norfolkspca.com/medservice/clomid-fertility-therapy/14/ here buy cheap expository essay on donald trump art postmodernism essay see sample thesis title proposal for it global response force cialis https://journeysmobilevet.com/edimprove/viagra-covered-blue-cross-blue-shield/26/ follow url buy clomid from canada case study topics in data structures plantas viagra natural beginning essay introduction https://shepherdstown.info/conclusion/examples-literary-essay-conclusions/17/ discount pills viagra how to make business proposal enter site introduction lines for essays problemas com o viagra prednisone on empty stomach results women taking viagra is celebrex better than ibuprofen proscar finasteride anti profiteering act 2015 essay sildenafil 50 mg precio en ecuador https://mjcs.org/sitejabber/research-parer/48/ best sites for hindi essays ayn rand essay contest atlas shrugged the movie https://awakenedhospitality.com/buy/tomar-viagra-natural/30/ source site follow site source url by | Jun 16, 2019 | Positions

Our Quality and Patient Safety and Clinical Practice and Research Committees are pleased to release our final position on Labeling. This is so important to our organization and profession to ensure quality and consistency for medical Cannabis products and...

Safe Institutional Policies

ISCPh believes in the proper use and storage of medical Cannabis. We’ve released our official position statement to ensure safety and prevent diversion. Check out our Institutional Policy here!  

Mandatory Clinical Education

We understand there is much work to be done to truly #DefineCannabisCare, but we also know it is better working together! Our committees are composed with members across 10 different Medical/Adult-Use states. Our first position has been created and approved by our...